Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for H.PIO Co. Ltd. (357230:KRX), powered by AI.
H.PIO Co. Ltd. is currently trading at ₩2,285. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for H.PIO Co. Ltd. on Alpha Lenz.
H.PIO Co. Ltd.'s P/E ratio is 11.2.
“H.PIO Co. Ltd. trades at a P/E of 11.2 (undervalued) with modest ROE of 5.7%.”
Ask for details →H.PIO Co. Ltd. is a notable entity within the pharmaceutical and biotechnology sector, primarily engaged in the research, development, and distribution of life-saving drugs and medical compounds. The company focuses on producing innovative solutions aimed at improving patient outcomes across a variety of therapeutic areas. Its product portfolio includes complex biopharmaceuticals, generic pharmaceuticals, and cutting-edge medical technologies. With a commitment to enhancing healthcare solutions, H.PIO Co. Ltd. invests substantially in research and development to remain at the forefront of medical advancements. Its operations impact global health markets by partnering with healthcare providers and institutions to ensure the availability and accessibility of quality medications. Known for its strategic collaborations and partnerships, H.PIO Co. Ltd. plays a significant role in both national and international pharmaceutical industries, contributing to the overarching goals of improved public health and chronic disease management.
“H.PIO Co. Ltd. trades at a P/E of 11.2 (undervalued) with modest ROE of 5.7%.”
Ask for details →H.PIO Co. Ltd. (ticker: 357230) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $94.4B.
The current price is ₩2,285 with a P/E ratio of 11.21x and P/B of 0.62x.
ROE is 5.69% and operating margin is 5.25%. Annual revenue is $258.2B.